IPSS-M Risk Calculator assists clinicians in stratifying risk for patients with myelodysplastic syndromes by integrating genomic, hematologic, and cytogenetic data. It supports personalized prognosis and clinical decision-making for hematologists. Developed by the MDS Foundation, Inc.
IPSS-M Risk Calculator sits in PulseGate's Health & fitness category. It helps clinicians accurately stratify MDS patient risk using genomic and clinical data. IPSS-M Risk Calculator is a B2B product aimed at hematologists. The product is available for free. IPSS-M Risk Calculator is available on iOS.
It is developed by MDS Foundation, Inc (United States), and the product first shipped in 2023. Across PulseGate's embedding index, IPSS-M Risk Calculator has few near neighbours, marking it as relatively distinct. Among its 5 catalogued features are risk calculation, genomic profiling, and personalized prognosis.
Latest indexed changes and source events
IPSS-M Risk Calculator discovered by the PulseGate indexer
Other apps tracked under the same category.
